S-Adenosylmethionine · AdoMet
SAM-e (S-adenosyl-L-methionine) is the universal methyl donor in human biology, participating in over 200 methyl-transfer reactions including DNA methylation, neurotransmitter synthesis (epinephrine from norepinephrine, melatonin from serotonin), phosphatidylcholine biosynthesis, creatine production, and detoxification of various xenobiotics. SAM-e is endogenously synthesized from methionine + ATP via methionine adenosyltransferase (MAT). Endogenous production declines with age, B12/folate deficiency, MTHFR polymorphisms, and chronic stress.
Take 30 min before meals on empty stomach for best absorption (enteric-coated forms). Split AM + lunch dose - DO NOT take late in day (can cause insomnia/activation). Start at 200mg twice daily, titrate up over 1-2 weeks. Pair with B-complex (especially B12 + methylfolate) to support full methylation cycle and prevent SAH/homocysteine accumulation.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
SAM-e is the universal methyl donor produced from methionine + ATP via MAT (methionine adenosyltransferase). It donates methyl groups via methyltransferase enzymes to acceptor molecules including DNA (DNMT enzymes), histones, neurotransmitters (catechol-O-methyltransferase converts norepinephrine to epinephrine; HIOMT converts N-acetylserotonin to melatonin), creatine precursors (GAMT), and phosphatidylcholine (PEMT). After donation, SAM-e becomes SAH (S-adenosyl homocysteine) which is recycled back through the methionine cycle.
The antidepressant mechanism is multifactorial: SAM-e supports synthesis of monoamine neurotransmitters (serotonin, norepinephrine, dopamine) via methylation-dependent enzyme regulation; it supports phosphatidylcholine production for neuronal membrane integrity; and it affects gene expression through DNA methylation in mood-relevant brain regions. Clinically, SAM-e shows antidepressant onset within 1-2 weeks (faster than SSRIs which typically take 4-6 weeks).
The osteoarthritis mechanism involves stimulation of glycosaminoglycan and proteoglycan synthesis in articular cartilage chondrocytes - mechanistically distinct from NSAID anti-inflammatory action. Animal studies confirm SAM-e increases proteoglycan content in articular cartilage. Joint pain reduction effect size is similar to NSAIDs but without the GI/cardiovascular risk profile. The liver-protective effects involve restoration of hepatic glutathione via methylation-dependent cysteine production and reduced oxidative stress in hepatocytes.
Days 3-14: Mood improvements begin in many users.
Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.
S-adenosylmethionine supplies methyl groups to many acceptors, including lipids, proteins, RNA, DNA, and a wide range of small molecules.
S-adenosylmethionine supplies methyl groups to many acceptors, including lipids, proteins, RNA, DNA, and a wide range of small molecules.
S-adenosylmethionine tRNA modification: unexpected/unsuspected implications of former/new players.
Evidence scope. Biochemistry review; supports methyl-donor function, not oral dose, efficacy, or timing.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Dose/route: 400mg via Oral, Twice daily. No checked live PubMed abstract supported this complete molecule/formulation/route/dose/frequency combination.
Primary safety claim: Mild GI effects (nausea, diarrhea, dyspepsia) - take with food if needed. No checked live abstract directly established this as the primary concern for the card's exact formulation and regimen.
Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.
Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.
Plasma
Enteric-coated oral
Moderate (~5-10% oral) due to extensive first-pass metabolism. Enteric coating + butanedisulfonate stabilization improves absorption.
Pharmacological effects sustained with twice-daily dosing. Antidepressant effects build over 1-4 weeks.
Hepatic metabolism via methylation reactions. Conversion to SAH then back to methionine via methionine cycle.
Storage. Store enteric-coated tablets in original blister pack at room temperature (20-25C) in cool, dry place. SAM-e is unstable in air and moisture - DO NOT remove tablets from blister pack until use. Refrigeration extends shelf life. Bulk SAM-e powder degrades quickly and is not recommended.
Classified as a dietary supplement in the US (no FDA pre-approval). Available widely over the counter. Prescription pharmaceutical in Italy, Germany, Spain, and other EU countries (licensed for depression and osteoarthritis). Major branded products include Nature Made SAM-e, Doctor's Best SAM-e (with butanedisulfonate stabilization).
Put it to work
Open SAM-e (S-Adenosyl Methionine) straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open SAM-e (S-Adenosyl Methionine) in the app →Go deeper
The complete SAM-e (S-Adenosyl Methionine) walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗Track it in OnePin. Log vials, draws, and protocols in the app.
Type a name, brand, or tool. Esc closes.